These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 39076493)

  • 1. Implantable Cardiac Devices in Patients with Brady- and Tachy-Arrhythmias: An Update of the Literature.
    Chick W; Monkhouse C; Muthumala A; Ahsan S; Papageorgiou N
    Rev Cardiovasc Med; 2024 May; 25(5):162. PubMed ID: 39076493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biventricular pacing (cardiac resynchronization therapy): an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(13):1-60. PubMed ID: 23074464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An update on cardiac implantable electronic devices for the general physician.
    Peal JE; Mathews IG; Runnett C; Thomas HE; Ripley DP
    J R Coll Physicians Edinb; 2018 Jun; 48(2):141-147. PubMed ID: 29992205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New frontiers in cardiac devices.
    Dennis AS; Behar JM
    Br J Hosp Med (Lond); 2020 Oct; 81(10):92-103. PubMed ID: 33135932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging Technologies in Electrophysiology: From Single-Chamber to Biventricular Leadless Pacemakers.
    Gill J
    Cardiology; 2022; 147(2):179-190. PubMed ID: 35038698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Need for pacing in patients who qualify for an implantable cardioverter-defibrillator: Clinical implications for the subcutaneous ICD.
    Kutyifa V; Rosero SZ; McNitt S; Polonsky B; Brown MW; Zareba W; Goldenberg I
    Ann Noninvasive Electrocardiol; 2020 Jul; 25(4):e12744. PubMed ID: 31994819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The modular cardiac rhythm management system: the EMPOWER leadless pacemaker and the EMBLEM subcutaneous ICD.
    Tjong FVY; Koop BE
    Herzschrittmacherther Elektrophysiol; 2018 Dec; 29(4):355-361. PubMed ID: 30382341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac Implantable Electronic Miniaturized and Micro Devices.
    Rav Acha M; Soifer E; Hasin T
    Micromachines (Basel); 2020 Sep; 11(10):. PubMed ID: 33003460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nontransvenous Cardiovascular Implantable Electronic Device Technology-A Review for the Anesthesiologist.
    Cody J; Graul T; Holliday S; Streckenbach S; Hussain N; Dalia AA; Cronin B; Hargrave J; Augoustides JG; Essandoh M
    J Cardiothorac Vasc Anesth; 2021 Sep; 35(9):2784-2791. PubMed ID: 33707106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implantable cardioverter defibrillators. Prophylactic use: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(14):1-74. PubMed ID: 23074465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implantable devices for management of chronic heart failure: defibrillators and biventricular pacing therapy.
    Pires LA
    Curr Opin Anaesthesiol; 2006 Feb; 19(1):69-74. PubMed ID: 16547436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lead or be led: an update on leadless cardiac devices for general physicians.
    Wiles BM; Roberts PR
    Clin Med (Lond); 2017 Feb; 17(1):33-36. PubMed ID: 28148576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should all implantable cardioverter defibrillators for ventricular arrhythmias be dual-chamber devices?
    Lee KL; Lau CP
    Curr Cardiol Rep; 2001 Nov; 3(6):447-50. PubMed ID: 11602074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-traditional implantable cardioverter-defibrillator configurations and insertion techniques: a review of contemporary options.
    Tonko JB; Rinaldi CA
    Europace; 2022 Feb; 24(2):181-192. PubMed ID: 34453529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hybrid therapy of atrial fibrillation.
    Santini M; Pignalberi C; Ricci R; Calò L
    Ital Heart J; 2002 Oct; 3(10):571-8. PubMed ID: 12478814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
    Wilkoff BL;
    Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac implantable electronic device and vascular access: Strategies to overcome problems.
    Kusztal M; Nowak K
    J Vasc Access; 2018 Nov; 19(6):521-527. PubMed ID: 29552930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current use of implantable electrical devices in Sweden: data from the Swedish pacemaker and implantable cardioverter-defibrillator registry.
    Gadler F; Valzania C; Linde C
    Europace; 2015 Jan; 17(1):69-77. PubMed ID: 25336667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A devices' game of thrones: cardiac resynchronization therapy vs. pacemaker.
    Moura-Ferreira S; Gonçalves H; Oliveira M; Primo J; Fonseca P; Ribeiro J; Santos E; Pelicano N; Martins D; Gama V
    Europace; 2017 Dec; 19(12):2042-2046. PubMed ID: 28430911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermittent pacemaker syndrome: revision of VVI pacemaker to a new cardiac pacing mode for tachy-brady syndrome.
    McCormick DJ; Shuck JW; Ansinelli RA
    Pacing Clin Electrophysiol; 1987 Mar; 10(2):372-7. PubMed ID: 2437541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.